BE683206A - - Google Patents

Info

Publication number
BE683206A
BE683206A BE683206DA BE683206A BE 683206 A BE683206 A BE 683206A BE 683206D A BE683206D A BE 683206DA BE 683206 A BE683206 A BE 683206A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE683206A publication Critical patent/BE683206A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/50Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to ring nitrogen atoms
    • C07D241/52Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE683206D 1964-08-31 1966-06-27 BE683206A (enExample)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39337164A 1964-08-31 1964-08-31
US468153A US3344022A (en) 1964-08-31 1965-06-29 Method of treating chronic respiratory disease in poultry

Publications (1)

Publication Number Publication Date
BE683206A true BE683206A (enExample) 1966-12-27

Family

ID=27014259

Family Applications (1)

Application Number Title Priority Date Filing Date
BE683206D BE683206A (enExample) 1964-08-31 1966-06-27

Country Status (6)

Country Link
US (1) US3344022A (enExample)
BE (1) BE683206A (enExample)
BR (1) BR6572470D0 (enExample)
CA (1) CA920596A (enExample)
DE (1) DE1620113A1 (enExample)
GB (1) GB1121104A (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2081491A1 (enExample) * 1970-02-05 1971-12-03 Pfizer

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3497594A (en) * 1967-06-01 1970-02-24 Pfizer & Co C Combinations of quinoxaline-di-n-oxides and tetracycline antibiotics
US3818007A (en) * 1970-03-18 1974-06-18 Pfizer Hydroxyalkyl esters of quinoxaline-di-n-oxide-2-carboxylic acid
US3884918A (en) * 1970-09-04 1975-05-20 Ciba Geigy Ag 2,3 Substituted, 5,6 or 6,7 ethylene or methylene dioxy quinoxalines
US3907994A (en) * 1971-04-20 1975-09-23 Pfizer Substituted alkyl esters quinoxaline-di-N-oxide-2-carboxylic acid as growth promoting agents
US3928608A (en) * 1972-03-14 1975-12-23 Ici Ltd Certain quinoxaline N-oxides used to combat fungi
US4012512A (en) * 1972-09-05 1977-03-15 Ciba-Geigy Corporation Animal feeds containing quinoxaline-di-n-oxide derivatives
US3926992A (en) * 1972-11-03 1975-12-16 Pfizer Aldol products of 2-quinoxalinecarboxaldehy-1,4-dioxides
US3991053A (en) * 1975-08-06 1976-11-09 Pfizer Inc. Antibacterial 1,3-dihydrofuro[3,4-b]quinoxaline 4,9-dioxides
FR2350096A1 (fr) * 1976-05-03 1977-12-02 Oreal Compositions destinees a la coloration de la peau a base de derives de la quinoxaline
US4303657A (en) * 1979-05-21 1981-12-01 International Minerals & Chemical Corp. Nitrohydroxyalkyl-substituted quinoxaxiline dioxides and alkanoic acid esters thereof
GB2171693A (en) * 1985-03-01 1986-09-03 Enrico Marotta Quinoxaline derivatives useful for treatment and prophylaxis of swine dysentry and as animal growth promotants
US6610274B1 (en) * 2000-12-22 2003-08-26 Wallace J. Gardner Anti-inflammatory composition comprising tetracycline
US20040029842A1 (en) * 2001-12-18 2004-02-12 Gardner Wallace J. Triglyceride lowering, common cold and pneumonia prevention composition comprising tetracycline, and methods of treating or preventing diseases using same
US20050079187A1 (en) * 2003-10-14 2005-04-14 Gardner Wallace J. Composition, kit and method for reducing plaque formation, tooth decay and incidence of caries
CN103664807A (zh) * 2013-12-02 2014-03-26 河北美荷药业有限公司 3-甲基-2-(甲氧基苯乙烯酮基)-喹喔啉-1,4-二氧化物及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2545786A (en) * 1951-03-20 S-methoxyquinoxaline-l
US2626259A (en) * 1953-01-20 Ffiii-ce
US2644000A (en) * 1950-05-24 1953-06-30 Ici Ltd New quinoxaline derivatives
US2890981A (en) * 1957-07-29 1959-06-16 Pfizer & Co C Anthelmintic compositions
US2921937A (en) * 1958-04-15 1960-01-19 Pfizer & Co C 1, 4-dibromo and 1, 4-di-acyloxy phenazines and process of preparing
US3080283A (en) * 1959-08-06 1963-03-05 Philips Corp Phenazine derivatives for combating nematodes

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2081491A1 (enExample) * 1970-02-05 1971-12-03 Pfizer

Also Published As

Publication number Publication date
US3344022A (en) 1967-09-26
DE1620113A1 (de) 1970-01-02
CA920596A (en) 1973-02-06
BR6572470D0 (pt) 1973-08-09
GB1121104A (en) 1968-07-24

Similar Documents

Publication Publication Date Title
AU442366B2 (enExample)
BE613833A (enExample)
BE642437A (enExample)
BE483969A (enExample)
BE507097A (enExample)
BE518974A (enExample)
BE554195A (enExample)
BE564626A (enExample)
BE584699A (enExample)
BE603534A (enExample)
BE637777A (enExample)
BE637333A (enExample)
BE621510A (enExample)
BE622126A (enExample)
BE623398A (enExample)
BE626083A (enExample)
BE626684A (enExample)
BE627057A (enExample)
BE627390A (enExample)
BE627931A (enExample)
BE628611A (enExample)
BE629793A (enExample)
BE632875A (enExample)
BE47396A (enExample)
BE636791A (enExample)

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: CHAS. PFIZER & CO. INC.

Effective date: 19860627